California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on May 1, 2026

May 1, 2026

New Memoir Recounts Mercury Poisoning, Medical Failure & Recovery Through Detoxification, Indigenous & Ancestral Healing

Indeterminate EIN Presswire

May 1, 2026

TSAOG Orthopaedics & Spine Receives HCCT Innovation Award for Contact Center Transformation

Indeterminate EIN Presswire

May 1, 2026

Workplace Trauma Is Pushing Black Women Out – Healing Is the Way Back

Indeterminate EIN Presswire

May 1, 2026

Strategist Cheetara Piry Documents How Outdated Digital Systems Are Blocking Mental Health Care Access

Indeterminate EIN Presswire

May 1, 2026

National AIDS Memorial Announces Recipients of the Mary Bowman Arts in Activism Award

Indeterminate EIN Presswire

May 1, 2026

Pennant Acquires Senior Living Communities in Arizona and Wisconsin

Indeterminate GlobeNewswire

May 1, 2026

Qué ocurre después del avance: En KFSH, la innovación se mide por la repetición

Indeterminate GlobeNewswire

May 1, 2026

O Que Acontece Depois do Grande Avanço: No KFSH, a Inovação é Medida pela Repetição

Indeterminate GlobeNewswire

May 1, 2026

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 1, 2026

Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer

Indeterminate GlobeNewswire

May 1, 2026

Celcuity's Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort

Indeterminate GlobeNewswire

May 1, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 1, 2026

Refills GLP-1 Weight Loss Claims Evaluated: The Most Affordable Personalized Semaglutide & Tirzepatide GLP1 Program with Online Doctor Support

Indeterminate GlobeNewswire

May 1, 2026

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 1, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 1, 2026

Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation

Indeterminate GlobeNewswire

May 1, 2026

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 1, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

May 1, 2026

InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System

Indeterminate GlobeNewswire

May 1, 2026

InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System

Indeterminate GlobeNewswire